87408-1
Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
Active
Term Description
This term was created for, but not limited in use to, the submitter's Theradiag Lisa-Tracker Ustekinumab and anti-Ustekinumab test kits.
Part Description
LP250851-5 Ustekinumab
Ustekinumab (UST) is a human immunoglobulin G1κ (IgG1κ) that binds sub-unit p40 of interleukin-12 (IL-12) and interleukin-23 (IL-23). IL-12 and IL-23 are parts of the Th1 and Th17 inflammatory pathways, respectively, and are important in the development of psoriasis. Psoriasis has pathogenic similarities to psoriatic arthritis (PsA) which is an inflammatory disorder that is often unresponsive to tumor necrosis factor (TNF) inhibitor therapy. Also, many patients with PsA who initially respond well to TNF inhibitors eventually stop responding. UST is not a TNF inhibitor and offers patients with PsA an alternative treatment which has been proven to be effective and safe for short-term use. The safety for long-term use of UST still needs further study. PMID: 24101949
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- Ustekinumab:
MCnc: Pt: Ser/Plas: Qn: IA - Long Common Name
- Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
- Short Name
- Ustekinumab SerPl IA-mCnc
- Display Name
- Ustekinumab IA [Mass/Vol]
- Consumer Name Alpha Get Info
- Ustekinumab, Blood
Part Model Get Info
- Component
- Ustekinumab
LP250851-5
- Analyte
- Ustekinumab
LP250851-5
- Component Numerator
- Ustekinumab
LP250851-5
- Component Numerator Core
- Ustekinumab
LP250851-5
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- MCnc
LP6827-2
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser/Plas
LP7576-4
- System Core
- Ser/Plas
LP7576-4
- Super System
- NULL
- Scale
- Qn
LP7753-9
- Method
- IA
LP217197-5
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.63
- Last Updated
- Version 2.73 (MIN)
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 6779
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 101144-4 | Ustekinumab and Ustekinumab Ab panel - Serum or Plasma |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Ustekinumab: |
| el-GR | Greek (Greece) | Ουστεκινουμάμπη: Synonyms: DRUG/TOX IA MCnc Pt Qn Ορός Ορός/Πλάσμα Ουστεκινουμάμπη Πλάσμα |
| es-ES | Spanish (Spain) | Ustekinumab: Synonyms: Cuantitativo |
| es-MX | Spanish (Mexico) | Ustekinumab: |
| fr-FR | French (France) | Ustekinumab: |
| it-IT | Italian (Italy) | Ustekinumab: Synonyms: Concentrazione di Massa Immunoassay Livelli farmacologici e tossicologia Plasma Punto nel tempo (episodio) Siero Siero o Plasma |
| nl-NL | Dutch (Netherlands) | ustekinumab: Synonyms: IA |
| zh-CN | Chinese (China) | 优特克单抗: Synonyms: 优特克单克隆抗体; |
Example Units
| Unit | Source |
|---|---|
| ug/mL | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://